This week PharmaShots’ news was all about the updates on Clinical Trials, Pharma, Biotech, COVID-19, Regulatory & MedTech. Check out our full report below:

Camurus Reports the P-III (ACROINNOVA 2) Trial Data of Octreotide SC Depot (CAM2029) for Treating Acromegaly

Read More: Camurus

Lexeo Therapeutics Reports Interim Data from P-I/II Study of LX2006 to Treat Friedreich Ataxia Cardiomyopathy

Read More: Lexeo Therapeutica

Roche Reports the P-I (CT-996-201) Study Data of CT-996 for Treating Obesity

Read More: Roche

Bayer Provides Update on P-III (ARANOTE) Study of Darolutamide to Treat Metastatic Hormone-Sensitive Prostate Cancer

Read More: Bayer

Sanofi Publishes the P-III (XTEND-Kids) Study Data of Altuviiio to Treat Children with Severe Hemophilia A in the NEJM

Read More: Sanofi                                                                                                    

Bionomics Reports the Commencement of P-III (AFFIRM-1) Study Evaluating BNC210 for Social Anxiety Disorder (SAD)

Read More: Bionomics                                                                                                 

Roche Reports the P-III (RHONE-X) Study Data of Vabysmo for the Treatment of Diabetic Macular Edema (DME)

Read More: Roche                                                                                                    

AbbVie Reports the Regulatory Submissions to the US FDA and EMA of Rinvoq (Upadacitinib) to Treat Giant Cell Arteritis (GCA)

Read More: AbbVie

Arrivo BioVentures’ RABI-767 Receives the US FDA’s Fast Track Designation for Treating Acute Pancreatitis

Read More: Arrivo BioVentures

Zai Lab and argenx Report the NMPA’s Approval of Efgartigimod Alfa SC Injection to Treat Generalized Myasthenia Gravis

Read More: Zai Lab & argenx

MindMed Receives US Patent for MM120 to Treat Generalized Anxiety Disorder

Read More: MindMed                                                                                                

Atara Biotherapeutics Reports the US FDA’s BLA Acceptance with Priority Review of Tabelecleucel to Treat Post-Transplant Lymphoproliferative Disease

Read More: Atara Biotherapeutics                                                       

Ono Pharmaceutical Reports the EMA’s Acceptance of MAA for Vimseltinib to Treat Tenosynovial Giant Cell Tumor (TGCT)

Read More: Ono Pharmaceutical                                                                           

Phathom Pharmaceuticals’ Voquezna Receives the US FDA’s Approval for Relieving Heartburn Associated with Non-Erosive GERD

Read More: Phathom Pharmaceuticals                                                                    

GSK Reports the EMA’s Acceptance of MAA for Blenrep Combinations to Treat Multiple Myeloma

Read More: GSK                                                                                                           

BMS Reports the EMA’s Validation of Application for Opdivo Plus Yervoy to Treat Hepatocellular Carcinoma

Read More: BMS                                                                                                         

Nona Biosciences Partners with Alaya.bio to Advance CAR-T Cell Therapy

Read More: Nona Biosciences & Alaya.bio

Enveric Biosciences Collaborates with Aries Science & Technology to Develop its Dermatitis Topical Product

Read More: Enveric Biosciences & Aries Science & Technology

SOTIO Biotech Collaborates with Biocytogen for Expanding ADC Pipeline

Read More: SOTIO Biotech                                                                                       

Orum Therapeutics Collaborates with Vertex Pharmaceuticals for the Development of Degrader-Antibody Conjugates

Read More: Orum & Vertex                                                                                      

SK Biopharmaceuticals Teams Up with Full-Life Technologies to Develop FL-091 for Multiple Solid Tumors

Read More: SK Biopharmaceuticals & Full-Life Technologies                            

Meitheal Acquires Rights of Nabriva’s Contepo, Expanding its Specialty Biopharmaceuticals Portfolio

Read More: Meitheal & Nabriva                                                                                

Oticon Medical Reports the US FDA’s Clearance of its Bone Conduction Hearing System

Read More: Oticon Medical

NextStep Arthropedix to Introduce TheRay Hip System

Read More: NextStep Arthropedix

Globus Medical Reports the US FDA’s Clearance of ExcelsiusFlex and ACTIFY 3D Total Knee Systems

Read More: Globus Medical                                                                              

Lantheus Strengthens its Alzheimer’s Disease Pipeline Through the Acquisition of Meilleur Technologies

Read More: Lantheus Strenthens & Meilleur Technologies

GE HealthCare to Expand its AI-Based Portfolio Through the Acquisition of Intelligent Ultrasound’s Business Unit

Read More: GE HealthCare & Intelligent Ultrasound

Dechra Pharmaceuticals to Acquire Invetx, Expanding its Monoclonal Antibody Portfolio for Companion Animals

Read More: Dechra Pharmaceuticals & Invetx                                                      

PetPace Reports the Availability of its AI-Based Pet Health Monitoring Collar Across Canada

Read More: PetPace

Subtle Medical’s AI-Based Synthetic Imaging Software Gains the US FDA’s Clearance

Read More: Subtle Medical                                   

Related Post: PharmaShots Weekly Snapshots (July 08 – July 12, 2024)